Docobo

Docobo’s platforms are commercially deployed across the UK NHS and internationally. Their DOC@HOME® solution has demonstrated improved care standards in EU clinical studies such as eSMART with cancer patients. The company’s technology supports proactive intervention, reduces GP workload, enables virtual wards in care homes/homes, and enhances out-of-hospital care through real-time data sharing between patients and clinicians. In Austria at the Medical University of Vienna haematology clinic, DOC@HOME® has been shown to improve symptom tracking for oncology outpatients. The RESTORE2 integration helps early detection of deterioration in residential settings.